Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREA powerful first-line, broad-spectrum topical medication administered twice a day for 7 days to treat otitis external in dogs.
LEARN MOREFor the vaccination of healthy 18-day old chicken embryos or chickens 1-day of age against standard and variant infectious bursal disease.
LEARN MORE